Terms: = Lymphoma AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Diagnosis
32 results:
1. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
2. A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature review.
Liu X; Duan Y; Wang G; Zhu P
Diagn Pathol; 2023 Sep; 18(1):105. PubMed ID: 37735390
[TBL] [Abstract] [Full Text] [Related]
3. Castleman Disease with mdm2/CDK4 Protein Expression: a Potential Mimic of Inflammatory Variant of Liposarcoma with Significant Consequences.
Georgantzoglou N; Baker M; Liu X; Kerr DA; Linos K
Int J Surg Pathol; 2022 Oct; 30(7):753-759. PubMed ID: 35147042
[TBL] [Abstract] [Full Text] [Related]
4. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.
Dlouhy I; Karube K; Enjuanes A; Salaverria I; Nadeu F; Ramis-Zaldivar JE; Valero JG; Rivas-Delgado A; Magnano L; Martin-García D; Pérez-Galán P; Clot G; Rovira J; Jares P; Balagué O; Giné E; Mozas P; Briones J; Sancho JM; Salar A; Mercadal S; Alcoceba M; Valera A; Campo E; López-Guillermo A
Br J Haematol; 2022 Feb; 196(3):589-598. PubMed ID: 34632572
[TBL] [Abstract] [Full Text] [Related]
5. Over expression of CDK4 and mdm2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
[TBL] [Abstract] [Full Text] [Related]
6. [Li-Fraumeni syndrome in a patient with multiple anaplastic oligodendrogliomas of the brain (a case report and literature review)].
Potapov AA; Abdilatipov AA; Okhlopkov VA; Gavrilov AG; Zakharova NE; Goryaynov SA; Kobyakov GL; Absalyamova OV; Kravchuk AD; Kulikov AS; Shugay SV; Nikitin PV; Batalov AI; Shelygin YA; Lyubchenko LN; Aliev MD; Spallone A
Zh Vopr Neirokhir Im N N Burdenko; 2018; 82(4):87-96. PubMed ID: 30137042
[TBL] [Abstract] [Full Text] [Related]
7. GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and mdm2.
Han Q; Xu X; Li J; Wang J; Bai L; Wang A; Wang W; Zhang B
Mol Med Rep; 2017 Nov; 16(5):6290-6298. PubMed ID: 28849107
[TBL] [Abstract] [Full Text] [Related]
8. Molecular genetic and cytogenetic analysis of a primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.
Kato K; Oh Y; Takita J; Gunji Y; Kobayashi C; Yoshimi A; Nakao T; Noma M; Koike K; Morimoto A; Iijima S; Hojo H; Tsuchida M
Int J Hematol; 2016 Feb; 103(2):196-201. PubMed ID: 26676804
[TBL] [Abstract] [Full Text] [Related]
9. The mdm2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma.
Hedström G; Thunberg U; Amini RM; Zainuddin N; Enblad G; Berglund M
Eur J Haematol; 2014 Dec; 93(6):500-8. PubMed ID: 24889555
[TBL] [Abstract] [Full Text] [Related]
10. Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.
Sarek G; Ma L; Enbäck J; Järviluoma A; Moreau P; Haas J; Gessain A; Koskinen PJ; Laakkonen P; Ojala PM
Oncogene; 2013 Feb; 32(9):1091-8. PubMed ID: 22469985
[TBL] [Abstract] [Full Text] [Related]
11. Detection of specific genetic abnormalities by fluorescence in situ hybridization in soft tissue tumors.
Miura Y; Keira Y; Ogino J; Nakanishi K; Noguchi H; Inoue T; Hasegawa T
Pathol Int; 2012 Jan; 62(1):16-27. PubMed ID: 22192800
[TBL] [Abstract] [Full Text] [Related]
12. Pharmacological activation of the p53 pathway in haematological malignancies.
Saha MN; Micallef J; Qiu L; Chang H
J Clin Pathol; 2010 Mar; 63(3):204-9. PubMed ID: 19955555
[TBL] [Abstract] [Full Text] [Related]
13. Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Hematology; 2009 Dec; 14(6):335-40. PubMed ID: 19941740
[TBL] [Abstract] [Full Text] [Related]
14. TP53 R72P and mdm2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility.
Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
Cancer Genet Cytogenet; 2009 Nov; 195(1):31-6. PubMed ID: 19837266
[TBL] [Abstract] [Full Text] [Related]
15. mdm2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians.
Bittenbring J; Parisot F; Wabo A; Mueller M; Kerschenmeyer L; Kreuz M; Truemper L; Landt O; Menzel A; Pfreundschuh M; Roemer K
BMC Cancer; 2008 Apr; 8():116. PubMed ID: 18433491
[TBL] [Abstract] [Full Text] [Related]
16. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract] [Full Text] [Related]
17. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.
Coffin CM; Hornick JL; Fletcher CD
Am J Surg Pathol; 2007 Apr; 31(4):509-20. PubMed ID: 17414097
[TBL] [Abstract] [Full Text] [Related]
18. HDM4 (hdmx) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target.
Han X; Garcia-Manero G; McDonnell TJ; Lozano G; Medeiros LJ; Xiao L; Rosner G; Nguyen M; Fernandez M; Valentin-Vega YA; Barboza J; Jones DM; Rassidakis GZ; Kantarjian HM; Bueso-Ramos CE
Mod Pathol; 2007 Jan; 20(1):54-62. PubMed ID: 17143258
[TBL] [Abstract] [Full Text] [Related]
19. Dedifferentiated liposarcoma with extensive lymphoid component.
Kuhnen C; Mentzel T; Sciot R; Lehnhardt M; Homann HH; Debiec-Rychter M
Pathol Res Pract; 2005; 201(4):347-53. PubMed ID: 15991843
[TBL] [Abstract] [Full Text] [Related]
20. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Davies AJ; Lee AM; Taylor C; Clear AJ; Goff LK; Iqbal S; Cuthbert-Heavens D; Calaminici M; Norton AJ; Lister TA; Fitzgibbon J
Leukemia; 2005 Aug; 19(8):1459-65. PubMed ID: 15902285
[TBL] [Abstract] [Full Text] [Related]
[Next]
